Vet_02-21-75)
At 72 weeks, mean weight loss was 15.0% (5mg), 19.5% (10mg), and 22.5% (15mg) versus 3.1% with placebo
These medicines, on a peripheral level, inhibit stomach emptying and intestinal motility, hence extending satiety signals
35 Supporting Mood and Sleep During Neuroendocrine Reset Neurotransmitter balance often shifts as appetite circuitry normalizes and patients adjust to new eating patterns
Compared to brand-name GLP-1 medications at retail price ($13,000 to $16,000 per year for Wegovy or Mounjaro without insurance), Mochi's compounded options represent substantial savings
With an FSA, theres no IRS penalty for ineligible spending